Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by FGPstockon Jan 23, 2023 12:42pm
302 Views
Post# 35240054

RE:RE:RE:RE:RE:RE:somethings gotta give...

RE:RE:RE:RE:RE:RE:somethings gotta give...
imo, putting roger back to the CEO position 5 years after his settlement is a business mistake. On most exchanges, he would be banned from being part of any public company. He is the one that admittedly committed fraud, and the ppl by his side are the current CEO and CFO. That being said, they will probably put him back as there is no one on the BOD or management that will say no to him. In regards to news, the lack of transparency at this company has always created the biggest challange for me. 9 months ago they expected to "receive" BTD in Dec 2022 and produce revenue Jan 2023. Then it was "apply" for BTD and some of the posters are now hoping for BTD and AA in 2023 when in the past it was discussed as 100% rubber stamp. We all seem to spend a lot more time guessing or trying to see if they would somthing in a way we can put a positive spin on it and keep our hopes up. Good news or bad, we are all owners of this company and it would be nice to have management give us a clear picture as to where things are and what they are looking to achieve going forward.
<< Previous
Bullboard Posts
Next >>